Joao Monteiro
@jminimmunoland
🏳️🌈 🇧🇷 Physician-scientist turned Chief Editor @NatureMedicine. Former Immunology editor @Cell - Opinions are my own. He/him/his
ID: 2364549031
http://www.nature.com/nm 27-02-2014 18:46:06
2,2K Tweet
3,3K Followers
670 Following
📢Our review "Long COVID science, research and policy" is out in Nature Medicine By Ziyad Al-Aly, MD Hannah Davis Lisa McCorkell Letícia Soares, PhD Sarah Wulf Hanson, PhD Prof. Akiko Iwasaki Eric Topol A thread nature.com/articles/s4159…
A new #LongCovid comprehensive review Nature Medicine nature.com/articles/s4159… by Ziyad Al-Aly, MD Hannah Davis Lisa McCorkell Letícia Soares, PhD Sarah Wulf Hanson, PhD Prof. Akiko Iwasaki and me This thread by Ziyad takes you through the essential points x.com/zalaly/status/…
#LongCovid is a defining health crisis of our time! In case you missed it: Our review on #LongCovid in Nature Medicine Long Covid has impacted at least 400 million people at an annual cost of $1 trillion nature.com/articles/s4159… 🧵here: x.com/zalaly/status/…
We're so excited to present this special issue! It was a true team effort, with contributions from all the Nature Methods editors: Lin Tang, Dr. Arunima Singh, Rita Strack, Madhura Mukhopadhyay, Lei Tang, Nina Vogt and Vivien Marx🐘📬⛅️.
Join Melissa McCradden and our fellow canaries 🦜 in developing responsible and safe practices in championing the translational trial (also known as silent trial) as we bridge the gap between #AI and patient benefit
Your Brain Age is less about mechanical ticks & more about entropic lifestyle & environment. In our Nature Medicine, brain clocks speed up due to dementia, exposome (economic inequality, pollution), gender-health disparities, & regional factors👉 nature.com/articles/s4159… 🧵1/6
🔥of the press Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial Nature Medicine 👇doi.org/10.1038/s41591… ESMO - Eur. Oncology #ESMOAmbassadors #ESMO24
A simultaneous publication of our BELLINI data The Netherlands Cancer Institute presented today as oral abstract on exploring nivo/ipi in TNBC without chemo. Thanks #ESMO24 and Nature Medicine!
Looking for PhD students/postdocs for my newly opened lab at the Institute of Human Biology of #Roche in Basel. We work on human lung, liver and gut #organoids. Send email + CV + motivation letter to [email protected] with header #IHB institutehumanbiology.com
A very impactful #ESMO24. Thanks Rebecca Dent and great ESMO staff ESMO - Eur. Oncology Kate Kronig! Minor note: Nature Medicine had even more concomitant papers of which 2 from The Netherlands Cancer Institute
Excited to share TxGNN, a model that identifies potential therapies from existing medicines for thousands of diseases. Trained across 17,080 diseases, TxGNN predicts drug candidates for conditions with limited or no treatment options, including rare diseases Nature Medicine
Looking forward to our symposium with Eric Vivier, Innate Pharma and many other friends and colleagues next week Thursday, Oct 3. Still time to register for FREE and hear about the next generation of immunotherapy on the horizon... ✍️ SIGN UP here >>> innate-symposium.com
As medical #AI development gathers momentum, a new study reveals that much work still needs to be done before the public will willingly embrace AI-based technologies in healthcare. News & Views from Roxana Daneshjou MD/PhD and colleagues StanfordDBDS nature.com/articles/s4159…
Interested in a PhD in Immunology? Come learn about the Immunology training area, PhD in Biomedical Sciences program Icahn School of Medicine at Mount Sinai Join enthusiastic research in basic scientific explorations to practical medical applications of the Immune System. All in NYC!